145 related articles for article (PubMed ID: 15117844)
1. Detection of acutely impaired microvascular reperfusion after infarct angioplasty with magnetic resonance imaging.
Taylor AJ; Al-Saadi N; Abdel-Aty H; Schulz-Menger J; Messroghli DR; Friedrich MG
Circulation; 2004 May; 109(17):2080-5. PubMed ID: 15117844
[TBL] [Abstract][Full Text] [Related]
2. Effects of primary angioplasty for acute myocardial infarction on early and late infarct size and left ventricular wall characteristics.
Baks T; van Geuns RJ; Biagini E; Wielopolski P; Mollet NR; Cademartiri F; van der Giessen WJ; Krestin GP; Serruys PW; Duncker DJ; de Feyter PJ
J Am Coll Cardiol; 2006 Jan; 47(1):40-4. PubMed ID: 16386662
[TBL] [Abstract][Full Text] [Related]
3. Characterization of microvascular dysfunction after acute myocardial infarction by cardiovascular magnetic resonance first-pass perfusion and late gadolinium enhancement imaging.
Yan AT; Gibson CM; Larose E; Anavekar NS; Tsang S; Solomon SD; Reynolds G; Kwong RY
J Cardiovasc Magn Reson; 2006; 8(6):831-7. PubMed ID: 17060106
[TBL] [Abstract][Full Text] [Related]
4. Prevention of left ventricular remodeling with granulocyte colony-stimulating factor after acute myocardial infarction: final 1-year results of the Front-Integrated Revascularization and Stem Cell Liberation in Evolving Acute Myocardial Infarction by Granulocyte Colony-Stimulating Factor (FIRSTLINE-AMI) Trial.
Ince H; Petzsch M; Kleine HD; Eckard H; Rehders T; Burska D; Kische S; Freund M; Nienaber CA
Circulation; 2005 Aug; 112(9 Suppl):I73-80. PubMed ID: 16159869
[TBL] [Abstract][Full Text] [Related]
5. Acute oedema in the evaluation of microvascular reperfusion and myocardial salvage in reperfused myocardial infarction with cardiac magnetic resonance imaging.
Phrommintikul A; Abdel-Aty H; Schulz-Menger J; Friedrich MG; Taylor AJ
Eur J Radiol; 2010 Jun; 74(3):e12-7. PubMed ID: 19375879
[TBL] [Abstract][Full Text] [Related]
6. Prognostic impact of contrast-enhanced CMR early after acute ST segment elevation myocardial infarction (STEMI) in a regional STEMI network: results of the "Herzinfarktverbund Essen".
Bruder O; Breuckmann F; Jensen C; Jochims M; Naber CK; Barkhausen J; Erbel R; Sabin GV;
Herz; 2008 Mar; 33(2):136-42. PubMed ID: 18344033
[TBL] [Abstract][Full Text] [Related]
7. Elective percutaneous coronary intervention immediately impairs resting microvascular perfusion assessed by cardiac magnetic resonance imaging.
Taylor AJ; Al-Saadi N; Abdel-Aty H; Schulz-Menger J; Messroghli DR; Gross M; Dietz R; Friedrich MG
Am Heart J; 2006 Apr; 151(4):891.e1-7. PubMed ID: 16569557
[TBL] [Abstract][Full Text] [Related]
8. Microvascular perfusion 1 week and 6 months after myocardial infarction by first-pass perfusion cardiovascular magnetic resonance imaging.
Bodí V; Sanchis J; López-Lereu MP; Núñez J; Sanz R; Palau P; Gómez C; Moratal D; Chorro FJ; Llácer A
Heart; 2006 Dec; 92(12):1801-7. PubMed ID: 16803939
[TBL] [Abstract][Full Text] [Related]
9. Late gadolinium-enhanced cardiovascular magnetic resonance evaluation of infarct size and microvascular obstruction in optimally treated patients after acute myocardial infarction.
Nijveldt R; Beek AM; Hofman MB; Umans VA; Algra PR; Spreeuwenberg MD; Visser CA; van Rossum AC
J Cardiovasc Magn Reson; 2007; 9(5):765-70. PubMed ID: 17891613
[TBL] [Abstract][Full Text] [Related]
10. Impact of primary coronary angioplasty delay on myocardial salvage, infarct size, and microvascular damage in patients with ST-segment elevation myocardial infarction: insight from cardiovascular magnetic resonance.
Francone M; Bucciarelli-Ducci C; Carbone I; Canali E; Scardala R; Calabrese FA; Sardella G; Mancone M; Catalano C; Fedele F; Passariello R; Bogaert J; Agati L
J Am Coll Cardiol; 2009 Dec; 54(23):2145-53. PubMed ID: 19942086
[TBL] [Abstract][Full Text] [Related]
11. Increase of myocardial salvage and left ventricular function recovery with intracoronary abciximab downstream of the coronary occlusion in patients with acute myocardial infarction treated with primary coronary intervention.
Bellandi F; Maioli M; Gallopin M; Toso A; Dabizzi RP
Catheter Cardiovasc Interv; 2004 Jun; 62(2):186-92. PubMed ID: 15170708
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value and determinants of a hypointense infarct core in T2-weighted cardiac magnetic resonance in acute reperfused ST-elevation-myocardial infarction.
Eitel I; Kubusch K; Strohm O; Desch S; Mikami Y; de Waha S; Gutberlet M; Schuler G; Friedrich MG; Thiele H
Circ Cardiovasc Imaging; 2011 Jul; 4(4):354-62. PubMed ID: 21518773
[TBL] [Abstract][Full Text] [Related]
13. Impaired myocardial perfusion score and inflammatory markers in patients undergoing primary angioplasty for acute myocardial infarction.
Exaire JE; Fathi RB; Brener SJ; Karha J; Ellis SG; Bhatt DL
Arch Cardiol Mex; 2006; 76(4):376-82. PubMed ID: 17315613
[TBL] [Abstract][Full Text] [Related]
14. Randomized early versus late abciximab in acute myocardial infarction treated with primary coronary intervention (RELAx-AMI Trial).
Maioli M; Bellandi F; Leoncini M; Toso A; Dabizzi RP
J Am Coll Cardiol; 2007 Apr; 49(14):1517-24. PubMed ID: 17418289
[TBL] [Abstract][Full Text] [Related]
15. Left ventricular function after ST-elevation myocardial infarction in patients treated with primary percutaneous coronary intervention and abciximab or tirofiban (from the Facilitated Angioplasty with Tirofiban or Abciximab [FATA] Trial).
Taglieri N; Saia F; Guiducci V; Tondi S; Conrotto F; Marrozzini C; Rocchi G; Biagini E; Reggiani ML; Giacometti P; Piovaccari G; Manari A; Marzocchi A;
Am J Cardiol; 2009 Mar; 103(6):785-90. PubMed ID: 19268732
[TBL] [Abstract][Full Text] [Related]
16. Intracoronary versus intravenous administration of abciximab in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention with thrombus aspiration: the comparison of intracoronary versus intravenous abciximab administration during emergency reperfusion of ST-segment elevation myocardial infarction (CICERO) trial.
Gu YL; Kampinga MA; Wieringa WG; Fokkema ML; Nijsten MW; Hillege HL; van den Heuvel AF; Tan ES; Pundziute G; van der Werf R; Hoseyni Guyomi S; van der Horst IC; Zijlstra F; de Smet BJ
Circulation; 2010 Dec; 122(25):2709-17. PubMed ID: 21098442
[TBL] [Abstract][Full Text] [Related]
17. Periprocedural abciximab administration in ST elevation myocardial infarction patients. Effect on severe microvascular obstruction beyond the restoration of epicardial coronary flow by primary angioplasty.
Tarantini G; Ramondo A; Corbetti F; Perazzolo Marra M; Cacciavillani L; Napodano M; Bilato C; Razzolini R; Iliceto S
Cardiology; 2008; 110(2):129-34. PubMed ID: 17971662
[TBL] [Abstract][Full Text] [Related]
18. Impact of coronary artery collaterals on infarct size assessed by serial cardiac magnetic resonance imaging after primary percutaneous coronary intervention in patients with acute myocardial infarction.
Yoon SJ; Ko YG; Kim JS; Moon JY; Kim YJ; Park S; Ha JW; Choi D; Jang Y; Chung N; Shim WH; Cho SY
Coron Artery Dis; 2009 Nov; 20(7):440-5. PubMed ID: 19730371
[TBL] [Abstract][Full Text] [Related]
19. Influence of transmurality, infarct size, and severe microvascular obstruction on left ventricular remodeling and function after primary coronary angioplasty.
Tarantini G; Razzolini R; Cacciavillani L; Bilato C; Sarais C; Corbetti F; Marra MP; Napodano M; Ramondo A; Iliceto S
Am J Cardiol; 2006 Oct; 98(8):1033-40. PubMed ID: 17027566
[TBL] [Abstract][Full Text] [Related]
20. Release of necrosis markers and cardiovascular magnetic resonance-derived microvascular perfusion in reperfused ST-elevation myocardial infarction.
Husser O; Bodi V; Sanchis J; Nunez J; Mainar L; Rumiz E; Lopez-Lereu MP; Monmeneu JV; Forteza MJ; Oltra R; Riegger GA; Chorro FJ; Llacer A
Thromb Res; 2009 Nov; 124(5):592-600. PubMed ID: 19540571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
